Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
2.42% (1D)
| Bid | 1.56 |
| Market Cap | 52.72M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -45.51M |
| EPS (ttm) | -1.31 |
| PE Ratio (ttm) | -1.29 |
| Forward PE | -1.65 |
| Analyst | Buy |
| Ask | 1.69 |
| Volume | 100,566 |
| Avg. Volume (20D) | 318,104 |
| Open | 1.65 |
| Previous Close | 1.65 |
| Day's Range | 1.61 - 1.69 |
| 52-Week Range | 1.03 - 2.41 |
| Beta | -0.53 |
About ATNM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATNM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATNM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+18.35%
Actinium Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
4 months ago
+16.53%
Actinium Pharmaceuticals shares are trading higher after the company announced it entered a research collaboration with Memorial Sloan Kettering for clinical expansion of Actimab-A's backbone therapy strategy.
2 months ago · accessnewswire.com
Levi & Korsinsky Urges Actinium (ATNM) Shareholders to Act Before Lead Plaintiff Deadline May 27, 2025NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal secu...
